Showing results (251-260 of 345) with videos related to
Sort By:
Pageof 35
BMC Infectious Diseases|April 3, 2012
Using sequence data to identify alternative routes and risk of infection: a case-study of campylobacter in ScotlandPaul R Bessell, Ovidiu Rotariu, Giles T Innocent, et al.Military Medicine|August 20, 2024
A PROMPT Update on Partial REBOA: Initial Clinical Data and Overview of the DoD-Funded Partial REBOA Outcomes Multicenter ProspecTive (PROMPT) StudyStephen Gondek, Susan Hamblin, Jessica Raley, et al.BMC Public Health|July 17, 2010
Geographic determinants of reported human Campylobacter infections in ScotlandPaul R Bessell, Louise Matthews, Alison Smith-Palmer, et al.The Journal of Infectious Diseases|January 5, 2024
Persistent Low-Level Variants in a Subset of Viral Genes Are Highly Predictive of Poor Outcome in Immunocompromised Patients With Cytomegalovirus InfectionCristina Venturini, Julia M Colston, Oscar Charles, et al.Plos One|January 26, 2019
Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantationSheila Lumley, Cameron Green, Hannah Rafferty, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2006
2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonistsRobert W Carling, Michael G N Russell, Kevin W Moore, et al.Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Pyrazolopyridinones as functionally selective GABAA ligandsWesley P Blackaby, John R Atack, Frances Bromidge, et al.Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.The Lancet. Global Health|October 28, 2017
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewLouisa Degenhardt, Amy Peacock, Samantha Colledge, et al.The Plant Cell|November 15, 2005
Functional genomic analysis of the AUXIN/INDOLE-3-ACETIC ACID gene family members in Arabidopsis thalianaPaul J Overvoorde, Yoko Okushima, José M Alonso, et al.Pageof 35